BETA: Please send your feedback!
Optigenex
OPGX:OTC
Biotechnology
—
null cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 2002
Optigenex, Inc. is engaged in the manufacturing and licensing of beauty, dietary supplements and personal care products. It also manufacturers, licenses and markets patented cellular DNA repair technology known as AC-11 to distributors and retailers in the dietary supplement, anti-aging topical skin care and cosmetic and cosmeceutical market categories. The company was founded on July 10, 2002 and is headquartered in Hoboken, NJ.
website
Headquarters
Executives
Name | Title | Gender |
Daniel A. Zwiren, MBA | President, Chief Executive & Financial Officer | Male |
Mindful Investing Summary
Optigenex - Competitors and Related Companies
How Optigenex stacks up to its peers in the Biotechnology industry or with competing business segments.
Optigenex
OPGX:OTC
Biotechnology
—
null cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Loading…